|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| CASH PROVIDED BY (USED IN): OPERATING ACTIVITIES | ||
| Net loss for the period | ||
| Adjustments and items not affecting cash and cash equivalents: | ||
| Depletion, depreciation, amortization and accretion | ||
| Fair value change losses (gains): | ||
| Investments-equity instruments | ||
| Investments-equity instruments (notes 6 and 19) | ||
| Investments-uranium (notes 6 and 19) | ||
| Investments-convertible debentures | ||
| Joint venture-equity share of (income) loss | ||
| Recognition of deferred revenue | ||
| Investments-debt instruments (notes 6 and 19) | ||
| Deferred consideration (note 6) | ||
| Investments-Capped Call options (notes 14 and 19) | ||
| Convertible notes -Embedded Derivates (notes 14 and 19) | ||
| Day one loss on convertible notes (notes 14 and 19) | ||
| Uranium pre-payment (note 11) | ||
| Investment in associate-equity pick up (note 6) | ||
| Joint venture-equity pick up (note 7) | ||
| Recognition of deferred revenue (note 11) | ||
| Loss (gain) on property, plant and equipment disposals | ||
| Post-employment benefit payments | ||
| Post-employment benefit payments (note 13) | ||
| Reclamation obligation income statement adjustment (note 12) | ||
| Reclamation obligation expenditures (note 12) | ||
| Reclamation obligation expenditures | ||
| Reclamation liability deposit from joint venture partner | ||
| Share-based compensation (note 17) | ||
| Foreign exchange gain (note 19) | ||
| Deferred income tax recovery (note 15) | ||
| Change in non-cash operating working capital items | ||
| Change in non-cash operating working capital items (note 19) | ||
| Net cash used in operating activities | ||
| INVESTING ACTIVITIES | ||
| Additions of property, plant and equipment (note 9) | ||
| Proceeds on disposal of investment - uranium (note 6) | ||
| Purchase of equity investments (note 6) | ||
| Purchase of Capped Call derivative options (note 14) | ||
| Proceeds on disposal of property, plant and equipment | ||
| Decrease in restricted cash and investments (note 8) | ||
| Purchase of investment in joint venture (note 7) | ||
| Purchase of equity investments | ||
| Purchase of investment-convertible debentures | ||
| Net cash (used in) provided by investing activities | ||
| FINANCING ACTIVITIES | ||
| Repayment of debt obligations | ||
| Proceeds from Convertible Notes, net of issue costs (note 14) | ||
| Proceeds from share issues, net of cash paid issue costs (note 16) | ||
| Proceeds from share options exercised | ||
| Proceeds from share options exercised (note 16) | ||
| Repayment of debt obligations (note 13) | ||
| Net cash provided by financing activities | ||
| Increase/(Decrease) in cash and cash equivalents | ||
| Foreign exchange effect on cash and cash equivalents | ||
| Cash and cash equivalents, beginning of period | ||
| Cash and cash equivalents, end of period |
Loading...
